Stay updated on Switch to Dolutegravir + Rilpivirine Clinical Trial

Sign up to get notified when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Switch to Dolutegravir + Rilpivirine Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    An NIH-wide banner about the terminology transition from “AI” to “SI” was added, and the displayed site revision changed from v3.7.1 to v3.7.2. The page otherwise continues to show a 403 error.
    Difference
    1%
    Check dated 2026-10-20T22:53:49.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changes from `v3.7.0` to `v3.7.1` while the page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T22:50:28.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Access to the study record is now blocked by a 403 Forbidden error page, replacing the prior detailed study content and navigation. This reflects an access restriction rather than a data update to the study record.
    Difference
    20%
    Check dated 2026-09-22T23:04:06.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.7.0, replacing the previous v3.6.6. This reflects a version update to the page rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-09-15T21:55:20.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.5 to v3.6.6, signaling a new release/patch rather than a content alteration. This appears to be a backend/format update rather than a change to study data or visible content.
    Difference
    0.0%
    Check dated 2026-09-01T18:35:31.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    A new line '2014 ( U.S. NIH Grant/Contract )' was added to the study's identifiers. This reflects the NIH funding source for the trial.
    Difference
    0.0%
    Check dated 2026-08-25T21:40:37.000Z thumbnail image

Stay in the know with updates to Switch to Dolutegravir + Rilpivirine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.